Caption Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Caption Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$885K	Buy	59,700 +19,700	+49%	+$288K	0.01%	1060
2025 Q4	$638K	Sell	40,000 -2,500	-6%	-$35.4K	﹤0.01%	1194
2025 Q3	$470K	Sell	42,500 -198,000	-82%	-$2.16M	﹤0.01%	1317
2025 Q2	$2.04M	Sell	240,500 -75,000	-24%	-$601K	0.02%	708
2025 Q1	$2.54M	Sell	315,500 -188,800	-37%	-$1.53M	0.02%	610
2024 Q4	$4.53M	Buy	504,300 +380,000	+306%	+$3.1M	0.04%	395
2024 Q3	$911K	Buy	124,300 +64,300	+107%	+$399K	0.01%	804
2024 Q2	$343K	Buy	+60,000	New	+$316K	0.01%	879
2024 Q1	–	Sell	-218,000	Closed	-$1.96M	–	1198
2023 Q4	$1.96M	Buy	218,000 +168,000	+336%	+$1.38M	0.03%	625
2023 Q3	$389K	Hold	50,000	–	–	0.01%	988
2023 Q2	$484K	Sell	50,000 -100,000	-67%	-$1.04M	0.01%	826
2023 Q1	$1.64M	Buy	150,000 +105,000	+233%	+$925K	0.03%	504
2022 Q4	$194K	Sell	45,000 -25,000	-36%	-$145K	﹤0.01%	1065
2022 Q3	$525K	Buy	70,000 +10,000	+17%	+$86.6K	0.01%	1062
2022 Q2	$603K	Hold	60,000	–	–	0.01%	1029
2022 Q1	$743K	Sell	60,000 -137,100	-70%	-$2.12M	0.01%	1051
2021 Q4	$4.51M	Buy	197,100 +107,100	+119%	+$2.54M	0.05%	487
2021 Q3	$1.99M	Sell	90,000 -70,000	-44%	-$1.11M	0.02%	755
2021 Q2	$2.07M	Buy	160,000 +40,000	+33%	+$510K	0.03%	665
2021 Q1	$1.56M	Sell	120,000 -101,200	-46%	-$1.47M	0.03%	578
2020 Q4	$3.06M	Buy	221,200 +11,200	+5%	+$163K	0.07%	337
2020 Q3	$3.09M	Sell	210,000 -62,200	-23%	-$901K	0.07%	312
2020 Q2	$4.42M	Sell	272,200 -60,000	-18%	-$961K	0.15%	190
2020 Q1	$4.82M	Buy	+332,200	New	+$5.86M	0.27%	98

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Caption Management's AUPH Position: Q4 2025 in Review

Caption Management sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2025, closing a stake of 4,330 shares — an estimated $61.4K sold.

Caption Management first reported a position in AUPH in Q4 2019 and held it in 18 quarters. The position peaked at $2.4M in Q2 2020. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

Caption Management reported no remaining Aurinia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Caption Management sold 4,330 Aurinia Pharmaceuticals shares in Q4 2025, an estimated $61.4K.
Caption Management first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 18 quarters.
Caption Management's Aurinia Pharmaceuticals position peaked at $2.4M in Q2 2020.
255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.